Products

What will AGI do for Acetaminophen/caffeine/guaifenesin/phenylephrine?

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The third component of this combination drug is an expectorant with the molecular formula C10H14O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears U.S. National Institutes of Health Compound Identifier 3516. The European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG. The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). The World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification. The fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula C9H13NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1WS297W6MV, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears U.S. National Institutes of Health Compound Identifier 6041. The European Medicines Agency schedules Phenylephrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09788MIG. The term PHENYLEPHRINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). The World Health Organization schedules phenylephrine in its Anatomical Therapeutic Chemical (ATC) Classification.